Literature DB >> 15521361

Dopamine receptor signaling.

Kim A Neve1, Jeremy K Seamans, Heather Trantham-Davidson.   

Abstract

The D1-like (D1, D5) and D2-like (D2, D3, D4) classes of dopamine receptors each has shared signaling properties that contribute to the definition of the receptor class, although some differences among subtypes within a class have been identified. D1-like receptor signaling is mediated chiefly by the heterotrimeric G proteins Galphas and Galphaolf, which cause sequential activation of adenylate cyclase, cylic AMP-dependent protein kinase, and the protein phosphatase-1 inhibitor DARPP-32. The increased phosphorylation that results from the combined effects of activating cyclic AMP-dependent protein kinase and inhibiting protein phosphatase 1 regulates the activity of many receptors, enzymes, ion channels, and transcription factors. D1 or a novel D1-like receptor also signals via phospholipase C-dependent and cyclic AMP-independent mobilization of intracellular calcium. D2-like receptor signaling is mediated by the heterotrimeric G proteins Galphai and Galphao. These pertussis toxin-sensitive G proteins regulate some effectors, such as adenylate cyclase, via their Galpha subunits, but regulate many more effectors such as ion channels, phospholipases, protein kinases, and receptor tyrosine kinases as a result of the receptor-induced liberation of Gbetagamma subunits. In addition to interactions between dopamine receptors and G proteins, other protein:protein interactions such as receptor oligomerization or receptor interactions with scaffolding and signal-switching proteins are critical for regulation of dopamine receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15521361     DOI: 10.1081/rrs-200029981

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  292 in total

1.  Infralimbic D2 receptors are necessary for fear extinction and extinction-related tone responses.

Authors:  Devin Mueller; Christian Bravo-Rivera; Gregory J Quirk
Journal:  Biol Psychiatry       Date:  2010-12-01       Impact factor: 13.382

2.  Scaffold hopping for identification of novel D(2) antagonist based on 3D pharmacophore modelling of illoperidone analogs.

Authors:  Radha Charan Dash; Sharad H Bhosale; Suhas M Shelke; Mugdha R Suryawanshi; Ashish M Kanhed; Kakasaheb R Mahadik
Journal:  Mol Divers       Date:  2011-12-08       Impact factor: 2.943

Review 3.  Genetics of aggression in voles.

Authors:  Kyle L Gobrogge; Zuoxin W Wang
Journal:  Adv Genet       Date:  2011       Impact factor: 1.944

4.  Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.

Authors:  Anna K Radke; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

Review 5.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

Review 6.  Dopamine in motivational control: rewarding, aversive, and alerting.

Authors:  Ethan S Bromberg-Martin; Masayuki Matsumoto; Okihide Hikosaka
Journal:  Neuron       Date:  2010-12-09       Impact factor: 17.173

7.  Dopaminergic modulation of ganglion-cell photoreceptors in rat.

Authors:  Matthew J Van Hook; Kwoon Y Wong; David M Berson
Journal:  Eur J Neurosci       Date:  2012-02-05       Impact factor: 3.386

Review 8.  GSK-3β activity and hyperdopamine-dependent behaviors.

Authors:  Yan-Chun Li; Wen-Jun Gao
Journal:  Neurosci Biobehav Rev       Date:  2010-08-18       Impact factor: 8.989

9.  Rapid dopaminergic and GABAergic modulation of calcium and voltage transients in dendrites of prefrontal cortex pyramidal neurons.

Authors:  Wen-Liang Zhou; Srdjan D Antic
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

10.  Carriers of a common variant in the dopamine transporter gene have greater dementia risk, cognitive decline, and faster ventricular expansion.

Authors:  Florence F Roussotte; Boris A Gutman; Derrek P Hibar; Sarah K Madsen; Katherine L Narr; Paul M Thompson
Journal:  Alzheimers Dement       Date:  2014-12-10       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.